PEQINI, KALIROI
PEQINI, KALIROI
Dipartimento di Scienze Farmaceutiche
Gold Nanoparticles Decorated with HPLC6-Derived Peptides as a Platform for Ice Recrystallization Inhibition
2025 E. Impresari, K. Peqini, T.P. Hogervorst, A. Faustini, F. Bodega, C. Porta, M.M. Pecchiari, G. Zanchetta, I.K. Voets, S. Pieraccini, S. Pellegrino
Breaking down and building up alpha‐synuclein: An insight on its N‐terminal domain
2024 K. Peqini, S. Attanasio, L. Feni, G. Cappelletti, S. Pellegrino
Mucosa-penetrating liposomes for esophageal local drug delivery
2024 S. Franze', F. Rama, E. Scarpa, M. Bruna Violatto, K. Peqini, C.G.M. Gennari, G. Anderluzzi, R. Camastra, A. Salmaso, G. Moscatiello, S. Pellegrino, L. Rizzello, P. Bigini, F. Cilurzo
DEVELOPMENT OF MOLECULAR PROBES ACTING ON aSYN/TUBULIN AND TAU/TUBULIN INTERACTION
2023 K. Peqini
Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
2022 M. Bollati, K. Peqini, L. Barone, C. Natale, M. Beeg, M. Gobbi, L. Diomede, M. Trucchi, M. de Rosa, S. Pellegrino
Multi-eGO: An in silico lens to look into protein aggregation kinetics at atomic resolution
2022 E. Scalone, L. Broggini, C. Visentin, D. Erba, F. Bačić Toplek, K. Peqini, S. Pellegrino, S. Ricagno, C. Paissoni, C. Camilloni
Multi-{eGO}: an in-silico lens to look into protein aggregation kinetics at atomic resolution
2022 E. Scalone, L. Broggini, C. Visentin, D. Erba, F. Ba( (c))i('(c)) Toplek, K. Peqini, S. Pellegrino, S. Ricagno, C. Paissoni, C. Camilloni
L- to D-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
2022 F. Ballabio, L. Broggini, C. Paissoni, X. Han, K. Peqini, B.M. Sala, R. Sun, T. Sandalova, A. Barbiroli, A. Achour, S. Pellegrino, S. Ricagno, C. Camilloni
α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques
2021 N. Bisi, L. Feni, K. Peqini, H. Pérez-Peña, S. Ongeri, S. Pieraccini, S. Pellegrino
Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination
2020 A.D. Duru, R. Sun, E.B. Allerbring, J. Chadderton, N. Kadri, X. Han, K. Peqini, H. Uchtenhagen, C. Madhurantakam, S. Pellegrino, T. Sandalova, P. Nygren, S.J. Turner, A. Achour